PAPITROL Trademark

Trademark Overview


On Friday, June 21, 2019, a trademark application was filed for PAPITROL with the United States Patent and Trademark Office. The USPTO has given the PAPITROL trademark a serial number of 79264599. The federal status of this trademark filing is REGISTERED as of Tuesday, December 29, 2020. This trademark is owned by Genexine, Inc.. The PAPITROL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical agents affecting sensory organs; pharmaceutical preparations for the treatment of psoriasis; pharmaceutical preparations for the treatment of short bowel syndrome; Pharmaceutical agents for treatment of diabetes; pharmaceutical agents affecting metabolism; pharmaceutical preparations for the treatment of rheumatoid arthritis; vaccines; pharmaceutical preparations for the treatment of anemia; fungicides; anti-inflammatories; pharmaceutical agents affecting digestive organs; cardiovascular pharmaceutical preparations for the treatment of cardiovascular disorders; medicated candy; Pharmaceutical preparations to treat HPV type 16 and/or 18 caused Precancerous Dysplasia and Cancer; pharmaceutical preparations for the treatment of inflammatory bowel disease; Pharmaceutical preparations being pills for inflammation treatment; pharmaceutical preparations for the treatment of dwarfism; disinfectants for hygiene purposes; pharmaceutical preparations for the treatment of cervical i...
papitrol

General Information


Serial Number79264599
Word MarkPAPITROL
Filing DateFriday, June 21, 2019
Status700 - REGISTERED
Status DateTuesday, December 29, 2020
Registration Number6230670
Registration DateTuesday, December 29, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 13, 2020

Trademark Statements


Goods and ServicesPharmaceutical agents affecting sensory organs; pharmaceutical preparations for the treatment of psoriasis; pharmaceutical preparations for the treatment of short bowel syndrome; Pharmaceutical agents for treatment of diabetes; pharmaceutical agents affecting metabolism; pharmaceutical preparations for the treatment of rheumatoid arthritis; vaccines; pharmaceutical preparations for the treatment of anemia; fungicides; anti-inflammatories; pharmaceutical agents affecting digestive organs; cardiovascular pharmaceutical preparations for the treatment of cardiovascular disorders; medicated candy; Pharmaceutical preparations to treat HPV type 16 and/or 18 caused Precancerous Dysplasia and Cancer; pharmaceutical preparations for the treatment of inflammatory bowel disease; Pharmaceutical preparations being pills for inflammation treatment; pharmaceutical preparations for the treatment of dwarfism; disinfectants for hygiene purposes; pharmaceutical preparations for the treatment of cervical intraepithelial neoplasia; pharmaceutical preparations for the treatment of systemic lupus erythematosus; Pharmaceutical agents for treating asthma, Pharmaceutical agents for the treatment of asthma; dermatological pharmaceutical products; antibiotic preparations; antibiotics; anti-cancer preparations; Antibody fusion protein for medical treatment in the nature of pharmaceutical preparations for the treatment of HPV type 16 and/or 18 caused Precancerous Dysplasia and Cancer; blood solvent, namely, blood plasma; pharmaceutical preparations for the treatment of neutropenia

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 16, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGenexine, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressKR

Party NameGenexine, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKR

Party NameGenexine, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events


Event DateEvent Description
Saturday, April 24, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, April 1, 2021FINAL DISPOSITION NOTICE SENT TO IB
Thursday, April 1, 2021FINAL DISPOSITION PROCESSED
Monday, March 29, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, December 29, 2020REGISTERED-PRINCIPAL REGISTER
Sunday, October 18, 2020NOTIFICATION PROCESSED BY IB
Tuesday, October 13, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 13, 2020PUBLISHED FOR OPPOSITION
Wednesday, September 30, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 30, 2020NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 23, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 10, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 10, 2020EXAMINER'S AMENDMENT ENTERED
Thursday, September 10, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, September 10, 2020EXAMINERS AMENDMENT E-MAILED
Thursday, September 10, 2020EXAMINERS AMENDMENT -WRITTEN
Friday, August 21, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 21, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 21, 2020ASSIGNED TO LIE
Wednesday, August 5, 2020NOTICE OF REVIVAL - E-MAILED
Tuesday, August 4, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 4, 2020PETITION TO REVIVE-GRANTED
Tuesday, August 4, 2020TEAS PETITION TO REVIVE RECEIVED
Friday, June 5, 2020ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, June 4, 2020ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, May 28, 2020NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, March 25, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 25, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 25, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, March 25, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 25, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 25, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, October 26, 2019REFUSAL PROCESSED BY IB
Saturday, October 5, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, October 5, 2019REFUSAL PROCESSED BY MPU
Friday, September 20, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, September 19, 2019NON-FINAL ACTION WRITTEN
Wednesday, September 11, 2019NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Tuesday, August 27, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, August 26, 2019NON-FINAL ACTION WRITTEN
Tuesday, August 20, 2019ASSIGNED TO EXAMINER
Tuesday, August 20, 2019APPLICATION FILING RECEIPT MAILED
Friday, August 16, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 8, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB